FDA 483 Citations for Dietary Supplement Product Complaints Under 21 CFR 111.553
"You did not establish written procedures for the requirements to review and investigate a product complaint." FDA investigators cited 21 CFR 111.553 with that wording 38 times on system-generated Form FDA 483s in fiscal year 2025.
Complaints are often the first sign that a dietary supplement has a quality or safety problem. They also connect to a separate legal duty: serious adverse events must be reported to FDA. A firm that has no complaint procedure usually has no reliable way to spot those events either.
What the citation means
Examples written after "Specifically" usually describe:
No written complaint procedure
Complaints handled by customer service or marketing with no quality review
No decision recorded on whether a complaint involves a possible failure to meet specifications
Complaints about illness or injury not evaluated as possible serious adverse events
No investigation of other batches when a complaint suggested a manufacturing problem
Complaint records missing the product, lot, complaint details or follow-up
Complaints from online reviews, social media or retailers not captured
What Part 111 requires
Procedures (111.553). You must establish and follow written procedures to fulfill the requirements of Subpart O, which covers product complaints.
Review and investigation (111.560). A qualified person must review all product complaints to determine whether the product complaint involves a possible failure of a dietary supplement to meet any of its specifications, or any other requirements of Part 111, including those specifications and other requirements that, if not met, may result in a risk of illness or injury. Quality control personnel must review and approve decisions about whether to investigate a product complaint and review and approve the findings and follow-up action of any investigation performed. The review and investigation must extend to all relevant batches and records.
Records (111.570). You must make and keep a written record of every product complaint that is related to good manufacturing practice. The record must include, where available, the name and description of the dietary supplement, its batch, lot or control number, the date the complaint was received and the complainant's contact information, the nature of the complaint including, if known, how the product was used, the reply to the complainant if any, and the findings of the investigation and follow-up action.
Serious adverse event reporting. Separately, section 761 of the Federal Food, Drug, and Cosmetic Act requires the manufacturer, packer or distributor whose name appears on the label of a dietary supplement marketed in the United States to report serious adverse events to FDA within 15 business days of receiving the report, and to keep records of all adverse event reports for 6 years.
How to respond to the 483
Part 111 does not set a deadline for responding, but most firms respond in writing within 15 business days of the close of the inspection, so FDA has the response before it decides on further action.
Review past complaints
Gather every complaint from all channels for a defined period, often two years. For each, record the evaluation: is it a possible failure to meet specifications, does it need investigation, and is it a serious adverse event? Investigate where needed and submit any overdue adverse event reports.
Write the complaint procedure
Intake from every channel, including phone, email, website, retailers, marketplaces and social media
Required information captured at intake
Review by a qualified person
Quality control approval of investigation decisions and findings
Investigation scope, including other batches and reserve samples
Screening for serious adverse events and the 15-business-day clock
Replies to complainants
Trending and links to corrective action
Records
Connect to other systems
Link complaints to returns, reserve sample testing, material review and recalls.
Train and verify
Train customer service, marketing, sales and quality staff who may receive complaints. Audit the complaint log.
What a compliant complaint procedure contains
Definition of a product complaint
Intake channels and responsibilities
Qualified person review
Quality control approval
Investigation, including other batches
Serious adverse event screening and reporting
Trending
Records and retention
Common mistakes in complaint responses
Treating complaints as customer service tickets only
Ignoring online reviews and marketplace messages
Investigating without quality control approval
Missing serious adverse events because no one screened for them
Fixing the procedure without reviewing past complaints
Example: how one response section might read
This illustrates structure only; your response must describe your own facts.
Observation 10: You did not establish written procedures for the review and investigation of product complaints. Specifically, 41 complaints received by customer service in the last year were not reviewed by quality control.
Response:
Retrospective review: All 41 complaints were reviewed by quality control on stated dates. Six involved possible specification failures and were investigated, including reserve sample testing. One met the definition of a serious adverse event and was reported to FDA on a stated date.
Corrective action: A complaint procedure was issued, covering intake from all channels, qualified person review, quality control approval, serious adverse event screening and trending.
Training: Customer service and marketing staff were trained to forward complaints the same day.
Verification: Quality control will review the complaint log weekly for three months.
Frequently asked questions
Is every customer comment a complaint?
A product complaint is a communication that alleges or suggests a failure to meet specifications or other Part 111 requirements, such as an illness, injury, foreign material, wrong label or unusual appearance. Document how you classify comments.
Who reports serious adverse events?
The manufacturer, packer or distributor whose name appears on the label, within 15 business days of receiving the report.
Do brand owners need a complaint procedure if a contract manufacturer makes the product?
Yes. Brand owners usually receive the complaints, and their name on the label makes them responsible for serious adverse event reporting.
How A.P. Lyon documents help
A.P. Lyon's Dietary Supplement cGMP Quality System (21 CFR 111) includes complaint handling and serious adverse event reporting procedures with intake forms and logs. The Supplement Brand Owner Compliance Pack covers complaints and adverse event reporting for brand owners.
Documents are editable Word and Excel files and must be adapted to your products and operations. Reporting decisions remain your responsibility.
Next steps
Review past complaints and report any overdue serious adverse events
Write a complaint procedure covering every intake channel
Require quality control approval of investigations
Respond in writing within 15 business days with dates for each action
Related guides: Returned Dietary Supplement Citations and Quality Control Procedure Citations.
To compare the complete system with the brand owner pack, see all dietary supplement documents.
Not sure where your quality system stands? Take the free QMS gap check: about 20 questions, an instant report of your gaps by clause, and the procedures that close each one.



Comments